About

Cellevate Story

From R&D to industrial supplier

1988

NanoLund – a part of Lund University (Sweden) is founded and has led to the creation of >10 nanotechnology spin off companies. Prominent public examples include Acconeer, Obducat, Acousort and Spermosens

2014

Cellevate founded 2014 as a spinout from NanoLund. Development of Generation 1 Cellevat3d™ = Conventional technology reinvented, in close collaborations with researchers

2016

Generation 2 Cellevat3d™ was developed to enable a larger product portfolio and improved performance in cell-co-culture applications

2017

Generation 1 and 2 Cellevat3d™ R&D Customized Solutions Sales in neurology, immunology and cancer

2020

Generation 3 Cellevat3d™ was developed

2021

Patent for production method submitted

2021 – 2024

Validations studies Cellevat3d™ in cell culture industrial applications. Pipeline development in downstream applications

2023

Launch and commercialization of cytokine analysis plates

2024

Launch and commercialization of Cellevat3d™ microcarriers